Schedule of Information for the Reportable Segments and Significant Expense Categories By Reportable Segment |
The following table summarizes financial information for the reportable segments for the three months ended June 30, 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Outpatient Medical | | Lab | | CCRC | | | | | | Total | Total revenues | | $ | 320,482 | | | $ | 209,205 | | | $ | 148,855 | | | | | | | $ | 678,542 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Healthpeak’s share of unconsolidated joint venture total revenues | | 7,183 | | | 7,358 | | | — | | | | | | | 14,541 | | | | | | | | | | | | | | | Noncontrolling interests’ share of consolidated joint venture total revenues | | (10,020) | | | — | | | — | | | | | | | (10,020) | | Operating expenses(1) | | (105,331) | | | (59,401) | | | (111,449) | | | | | | | (276,181) | | Healthpeak’s share of unconsolidated joint venture operating expenses | | (2,695) | | | (1,898) | | | — | | | | | | | (4,593) | | Noncontrolling interests’ share of consolidated joint venture operating expenses | | 2,801 | | | — | | | — | | | | | | | 2,801 | | | | | | | | | | | | | | | Adjustments to NOI(2) | | (10,813) | | | (12,488) | | | (843) | | | | | | | (24,144) | | Adjusted NOI for reportable segments | | $ | 201,607 | | | $ | 142,776 | | | $ | 36,563 | | | | | | | $ | 380,946 | | Plus: Adjustments to NOI(2) | | | | | | | | | | | | 24,144 | | Interest income and other | | | | | | | | | | | | 15,806 | | Interest expense | | | | | | | | | | | | (75,063) | | Depreciation and amortization | | | | | | | | | | | | (265,916) | | General and administrative | | | | | | | | | | | | (20,764) | | Transaction and merger-related costs | | | | | | | | | | | | (10,215) | | Impairments and loan loss reserves, net | | | | | | | | | | | | (3,499) | | Gain (loss) on sales of real estate, net | | | | | | | | | | | | 1,636 | | | | | | | | | | | | | | | Other income (expense), net | | | | | | | | | | | | (4,692) | | | | | | | | | | | | | | | Less: Healthpeak’s share of unconsolidated joint venture Adjusted NOI | | | | | | | | | | | | (9,948) | | Plus: Noncontrolling interests’ share of consolidated joint venture Adjusted NOI | | | | | | | | | | | | 7,219 | | Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures | | | | | | $ | 39,654 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
_______________________________________ (1)See reconciliation of significant expense categories below. (2)Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company’s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests’ share of income (loss) generated by consolidated joint ventures. The following table summarizes the Company’s significant expense categories by reportable segment for the three months ended June 30, 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | Outpatient Medical | | Lab | | CCRC | Compensation and property management | | $ | 15,009 | | | $ | 8,277 | | | $ | 71,745 | | Food | | — | | | — | | | 6,782 | | Real estate taxes | | 25,300 | | | 18,989 | | | 4,324 | | Repairs and maintenance | | 15,389 | | | 8,202 | | | 4,873 | | Utilities | | 18,332 | | | 10,687 | | | 5,719 | | Other segment items(1) | | 31,301 | | | 13,246 | | | 18,006 | | Operating expenses | | $ | 105,331 | | | $ | 59,401 | | | $ | 111,449 | |
_______________________________________ (1)Other segment items for each segment include: •Outpatient medical and lab – (i) Cleaning expense, (ii) ground rent expense, (iii) insurance expense, (iv) roads and grounds expense, (v) security expense, and (vi) other administrative expense. •CCRC – (i) Cleaning and supplies, (ii) insurance expense, (iii) marketing expense, and (iv) other administrative expense. The following table summarizes financial information for the reportable segments for the three months ended June 30, 2024 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Outpatient Medical | | Lab | | CCRC | | | | | | Total | | Total revenues | | $ | 332,515 | | | $ | 214,266 | | | $ | 140,891 | | | | | | | $ | 687,672 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Healthpeak’s share of unconsolidated joint venture total revenues | | 6,903 | | | 4,301 | | | — | | | | | | | 11,204 | | | | | | | | | | | | | | | | | Noncontrolling interests’ share of consolidated joint venture total revenues | | (9,341) | | | (33) | | | — | | | | | | | (9,374) | | | Operating expenses(1) | | (111,702) | | | (56,656) | | | (105,469) | | | | | | | (273,827) | | | Healthpeak’s share of unconsolidated joint venture operating expenses | | (2,464) | | | (1,528) | | | — | | | | | | | (3,992) | | | Noncontrolling interests’ share of consolidated joint venture operating expenses | | 2,609 | | | 9 | | | — | | | | | | | 2,618 | | | | | | | | | | | | | | | | | Adjustments to NOI(2) | | (10,430) | | | (13,289) | | | (1,739) | | | | | | | (25,458) | | | Adjusted NOI for reportable segments | | $ | 208,090 | | | $ | 147,070 | | | $ | 33,683 | | | | | | | $ | 388,843 | | | Plus: Adjustments to NOI(2) | | | | | | | | | | | | 25,458 | | | Interest income and other | | | | | | | | | | | | 7,832 | | | Interest expense | | | | | | | | | | | | (74,910) | | | Depreciation and amortization | | | | | | | | | | | | (283,498) | | | General and administrative | | | | | | | | | | | | (26,718) | | | Transaction and merger-related costs | | | | | | | | | | | | (7,759) | | | Impairments and loan loss reserves, net | | | | | | | | | | | | 553 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gain (loss) on sales of real estate, net | | | | | | | | | | | | 122,044 | | | Other income (expense), net | | | | | | | | | | | | 4,004 | | | | | | | | | | | | | | | | | Less: Healthpeak’s share of unconsolidated joint venture Adjusted NOI | | | | | | | | | | | | (7,212) | | | Plus: Noncontrolling interests’ share of consolidated joint venture Adjusted NOI | | | | | | | | | | | | 6,756 | | | Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures | | | | | | $ | 155,393 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
_______________________________________ (1)See reconciliation of significant expense categories below. (2)Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company’s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests’ share of income (loss) generated by consolidated joint ventures. The following table summarizes the Company’s significant expense categories by reportable segment for the three months ended June 30, 2024 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | Outpatient Medical | | Lab | | CCRC | Compensation and property management | | $ | 15,177 | | | $ | 8,045 | | | $ | 68,485 | | Food | | — | | | — | | | 6,605 | | Real estate taxes | | 27,806 | | | 18,808 | | | 4,276 | | Repairs and maintenance | | 16,504 | | | 7,206 | | | 4,578 | | Utilities | | 18,796 | | | 10,913 | | | 5,373 | | Other segment items(1) | | 33,419 | | | 11,684 | | | 16,152 | | Operating expenses | | $ | 111,702 | | | $ | 56,656 | | | $ | 105,469 | |
_______________________________________ (1)Other segment items for each segment include: •Outpatient medical and lab – (i) Cleaning expense, (ii) ground rent expense, (iii) insurance expense, (iv) roads and grounds expense, (v) security expense, and (vi) other administrative expense. •CCRC – (i) Cleaning and supplies, (ii) insurance expense, (iii) marketing expense, and (iv) other administrative expense. The following table summarizes financial information for the reportable segments for the six months ended June 30, 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Outpatient Medical | | Lab | | CCRC | | | | | | Total | Total revenues | | $ | 641,030 | | | $ | 426,798 | | | $ | 297,782 | | | | | | | $ | 1,365,610 | | | | | | | | | | | | | | | Healthpeak’s share of unconsolidated joint venture total revenues | | 14,442 | | | 10,158 | | | — | | | | | | | 24,600 | | Noncontrolling interests’ share of consolidated joint venture total revenues | | (19,993) | | | — | | | — | | | | | | | (19,993) | | Operating expenses(1) | | (210,557) | | | (117,059) | | | (221,708) | | | | | | | (549,324) | | Healthpeak’s share of unconsolidated joint venture operating expenses | | (5,689) | | | (3,564) | | | — | | | | | | | (9,253) | | Noncontrolling interests’ share of consolidated joint venture operating expenses | | 5,580 | | | — | | | — | | | | | | | 5,580 | | | | | | | | | | | | | | | Adjustments to NOI(2) | | (22,895) | | | (27,325) | | | (843) | | | | | | | (51,063) | | Adjusted NOI for reportable segments | | $ | 401,918 | | | $ | 289,008 | | | $ | 75,231 | | | | | | | $ | 766,157 | | Plus: Adjustments to NOI(2) | | | | | | | | | | | | 51,063 | | Interest income and other | | | | | | | | | | | | 31,627 | | Interest expense | | | | | | | | | | | | (147,756) | | Depreciation and amortization | | | | | | | | | | | | (534,462) | | General and administrative | | | | | | | | | | | | (46,882) | | Transaction and merger-related costs | | | | | | | | | | | | (15,749) | | Impairments and loan loss reserves, net | | | | | | | | | | | | 63 | | Gain (loss) on sales of real estate, net | | | | | | | | | | | | 1,636 | | | | | | | | | | | | | | | Other income (expense), net | | | | | | | | | | | | (10,818) | | | | | | | | | | | | | | | Less: Healthpeak’s share of unconsolidated joint venture Adjusted NOI | | | | | | | | | | | | (15,347) | | Plus: Noncontrolling interests’ share of consolidated joint venture Adjusted NOI | | | | | | | | | | | | 14,413 | | Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures | | | | | | $ | 93,945 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
_______________________________________ (1)See reconciliation of significant expense categories below. (2)Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company’s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests’ share of income (loss) generated by consolidated joint ventures. The following table summarizes the Company’s significant expense categories by reportable segment for the six months ended June 30, 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | Outpatient Medical | | Lab | | CCRC | Compensation and property management | | $ | 29,638 | | | $ | 16,587 | | | $ | 141,748 | | Food | | — | | | — | | | 13,225 | | Real estate taxes | | 49,379 | | | 38,010 | | | 8,832 | | Repairs and maintenance | | 30,892 | | | 15,560 | | | 9,719 | | Utilities | | 36,244 | | | 21,110 | | | 11,382 | | Other segment items(1) | | 64,404 | | | 25,792 | | | 36,802 | | Operating expenses | | $ | 210,557 | | | $ | 117,059 | | | $ | 221,708 | |
_______________________________________ (1)Other segment items for each segment include: •Outpatient medical and lab – (i) Cleaning expense, (ii) ground rent expense, (iii) insurance expense, (iv) roads and grounds expense, (v) security expense, and (vi) other administrative expense. •CCRC – (i) Cleaning and supplies, (ii) insurance expense, (iii) marketing expense, and (iv) other administrative expense. The following table summarizes financial information for the reportable segments for the six months ended June 30, 2024 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Outpatient Medical | | Lab | | CCRC | | | | | | Total | Total revenues | | $ | 570,787 | | | $ | 438,027 | | | $ | 279,667 | | | | | | | $ | 1,288,481 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Healthpeak’s share of unconsolidated joint venture total revenues | | 9,642 | | | 9,162 | | | — | | | | | | | 18,804 | | | | | | | | | | | | | | | Noncontrolling interests’ share of consolidated joint venture total revenues | | (18,217) | | | (196) | | | — | | | | | | | (18,413) | | Operating expenses(1) | | (192,970) | | | (113,496) | | | (211,090) | | | | | | | (517,556) | | Healthpeak’s share of unconsolidated joint venture operating expenses | | (3,547) | | | (2,852) | | | — | | | | | | | (6,399) | | Noncontrolling interests’ share of consolidated joint venture operating expenses | | 5,039 | | | 52 | | | — | | | | | | | 5,091 | | | | | | | | | | | | | | | Adjustments to NOI(2) | | (16,556) | | | (34,724) | | | (1,739) | | | | | | | (53,019) | | Adjusted NOI for reportable segments | | $ | 354,178 | | | $ | 295,973 | | | $ | 66,838 | | | | | | | $ | 716,989 | | Plus: Adjustments to NOI(2) | | | | | | | | | | | | 53,019 | | Interest income and other | | | | | | | | | | | | 13,583 | | Interest expense | | | | | | | | | | | | (135,817) | | Depreciation and amortization | | | | | | | | | | | | (502,717) | | General and administrative | | | | | | | | | | | | (50,017) | | Transaction and merger-related costs | | | | | | | | | | | | (114,979) | | Impairments and loan loss reserves, net | | | | | | | | | | | | (10,905) | | Gain (loss) on sales of real estate, net | | | | | | | | | | | | 125,299 | | | | | | | | | | | | | | | Other income (expense), net | | | | | | | | | | | | 82,520 | | | | | | | | | | | | | | | Less: Healthpeak’s share of unconsolidated joint venture Adjusted NOI | | | | | | | | | | | | (12,405) | | Plus: Noncontrolling interests’ share of consolidated joint venture Adjusted NOI | | | | | | | | | | | | 13,322 | | Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures | | | | | | $ | 177,892 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | _______________________________________(1)See reconciliation of significant expense categories below. (2)Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company’s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests’ share of income (loss) generated by consolidated joint ventures. The following table summarizes the Company’s significant expense categories by reportable segment for the six months ended June 30, 2024 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | Outpatient Medical | | Lab | | CCRC | Compensation and property management | | $ | 26,275 | | | $ | 16,422 | | | $ | 136,107 | | Food | | — | | | — | | | 13,069 | | Real estate taxes | | 47,934 | | | 38,705 | | | 8,577 | | Repairs and maintenance | | 28,096 | | | 13,818 | | | 9,192 | | Utilities | | 31,682 | | | 22,097 | | | 10,708 | | Other segment items(1) | | 58,983 | | | 22,454 | | | 33,437 | | Operating expenses | | $ | 192,970 | | | $ | 113,496 | | | $ | 211,090 | |
_______________________________________ (1)Other segment items for each segment include: •Outpatient medical and lab – (i) Cleaning expense, (ii) ground rent expense, (iii) insurance expense, (iv) roads and grounds expense, (v) security expense, and (vi) other administrative expense. •CCRC – (i) Cleaning and supplies, (ii) insurance expense, (iii) marketing expense, and (iv) other administrative expense.
|